SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
9 references·16 citing·39 second hop
Sertraline for social phobia: a double-blind, placebo-controlled crossover study (1995)Sertraline for social phobia: a double-bl…Social Phobia (2015)Social PhobiaPsychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine (1994)Psychopharmacological treatme…Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Lifetime and 12-Month Prevale…Treatment of Social Phobia With Clonazepam and Placebo (1993)Treatment of Social Phobia Wi…Pharmacotherapy of Social Phobia (1992)Pharmacotherapy of Social Pho…Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder (1988)Return of symptoms after disc…Social Phobia (1985)Social PhobiaBrief standard self-rating for phobic patients (1979)Brief standard self-rating fo…A New Depression Scale Designed to be Sensitive to Change (1979)A New Depression Scale Design…World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders (2007)World Federation of Societies…Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder (2005)Venlafaxine Extended Release …Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder (2004)Efficacy of the Novel Anxioly…Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study (2004)Efficacy and tolerability of …Pharmacological treatment of social anxiety disorder: A meta-analysis (2003)Pharmacological treatment of …Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial (2003)Exposure therapy and sertrali…World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (2002)World Federation of Societies…Social Anxiety Disorder in Childhood and Adolescence: Current Status and Future Directions (2001)Social Anxiety Disorder in Ch…Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study (2001)Sertraline Treatment of Gener…Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment (2000)Social phobia: diagnosis and …A Comparison of the Efficacy of Clonazepam and Cognitive-Behavioral Group Therapy for the Treatment of Social Phobia (2000)A Comparison of the Efficacy …Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety (1998)Clinical utility of the selec…A Comparison of Social Phobia Outcome Measures in Cognitive-Behavioral Group Therapy (1998)A Comparison of Social Phobia…Moclobemide in Social Phobia (1997)Moclobemide in Social PhobiaA Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders (1997)A Risk-Benefit Assessment of …A Computer-Administered Telephone Interview to Identify Mental Disorders (1997)A Computer-Administered Telep…A RATING SCALE FOR DEPRESSION (1960)Clomipramine Treatment of Obsessive-Compulsive Disorder (1980)Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology (1987)Clomipramine in obsessive-compulsive disorder (1990)Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis (1998)Obsessive–Compulsive Disorder (2004)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)Development of a Rating Scale for Primary Depressive Illness (1967)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study (1999)Paroxetine in social phobia/social anxiety disorder (1999)Social Anxiety Disorder (2008)ECDEU Assessment Manual for Psychopharmacology (1976)Cognitive-behavioral group therapy versus phenelzine in social phobia: Long term outcome (1999)Measurement of social-evaluative anxiety. (1969)Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia (1998)Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale (2002)Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder (2006)The functioning and well-being of depressed patients. Results from the Medical Outcomes Study (1989)The Structured Clinical Interview for DSM-III-R (SCID) (1992)Interactive voice response: Review of studies 1989–2000 (2002)Randomized trial of brief motivational treatments for pathological gamblers: More is not necessarily better. (2009)Pragmatic characteristics of patient-reported outcome measures are important for use in clinical practice (2015)Diagnostic Criteria for Use in Psychiatric Research (1972)The PHQ-9 (2001)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)The validity of the Hospital Anxiety and Depression Scale (2002)National Institute of Mental Health Diagnostic Interview Schedule (1981)The Structured Clinical Interview for DSM-III-R (SCID) (1992)Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. (2003)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder (2018)Psychometric properties of the Social Phobia Inventory (SPIN) (2000)Cognitive-Behavioral Therapy for Adult Anxiety Disorders (2008)The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods (2008)Cognitive Factors that Maintain Social Anxiety Disorder: a Comprehensive Model and its Treatment Implications (2007)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)Treatment of anxiety disorders (2017)
this work references cited by second hop

References

  • 1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
  • 1994Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States12,377 cited
  • 2015Social Phobia2,264 cited
  • 1979Brief standard self-rating for phobic patients1,801 cited
  • 1985Social Phobia576 cited
  • 1992Pharmacotherapy of Social Phobia333 cited
  • 1988Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder301 cited
  • 1994Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine270 cited
  • 1993Treatment of Social Phobia With Clonazepam and Placebo265 cited

Cited by

  • 1997A Computer-Administered Telephone Interview to Identify Mental Disorders238 cited
  • 2004Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder227 cited
  • 2001Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study224 cited
  • 2001Social Anxiety Disorder in Childhood and Adolescence: Current Status and Future Directions204 cited
  • 1998Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety196 cited
  • 1997

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders
181 cited
  • 2000A Comparison of the Efficacy of Clonazepam and Cognitive-Behavioral Group Therapy for the Treatment of Social Phobia175 cited
  • 2003Pharmacological treatment of social anxiety disorder: A meta-analysis170 cited
  • 2002World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders167 cited
  • 2007World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders165 cited
  • 2004Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study164 cited
  • 2005Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder161 cited
  • 2000Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment153 cited
  • 2003Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial151 cited
  • 1998A Comparison of Social Phobia Outcome Measures in Cognitive-Behavioral Group Therapy151 cited
  • 1997Moclobemide in Social Phobia150 cited